Screener
Rapport Therapeutics, Inc. RAPP Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Rapport Therapeutics, Inc.’s reported figures.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
FAQ
- What is Rapport Therapeutics, Inc.'s enterprise value?
- Rapport Therapeutics, Inc. (RAPP) reported enterprise value of $1.94B in Q2 2026.
- How has Rapport Therapeutics, Inc.'s enterprise value changed year-over-year?
- Rapport Therapeutics, Inc.'s enterprise value increased by 374.6% year-over-year, from $408.64M to $1.94B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Rapport Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude